Related references
Note: Only part of the references are listed.Five-year follow-up of the endothelial progenitor cell capturing stent versus the paxlitaxel-eluting stent in de novo coronary lesions with a high risk of coronary restenosis
Pier Woudstra et al.
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS (2018)
An Evaluation of the Bioengineered COMBO Dual-Therapy CD34 Antibody-Covered Sirolimus-Eluting Coronary Stent Compared With a Cobalt-Chromium Everolimus-Eluting Stent in Patients With Acute Coronary Syndromes: Insights From Optical Coherence Tomography Imaging Analysis
Milosz Jaguszewski et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2017)
Clinical outcomes after percutaneous coronary intervention with the COMBO stent versus Resolute Integrity and PROMUS Element stents: a propensity-matched analysis
Deborah N. Kalkman et al.
EUROINTERVENTION (2017)
Ten-year clinical outcomes of first-generation drug-eluting stents: the Sirolimus-Eluting vs. Paclitaxel-Eluting Stents for Coronary Revascularization (SIRTAX) VERY LATE trial
Kyohei Yamaji et al.
EUROPEAN HEART JOURNAL (2016)
Total ischaemic time and 9-year outcomes in STEMI patients treated with pPCI
M. Polanska-Skrzypczyk et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2015)
Efficiency of Statin Treatment on EPC Recruitment Depends on Baseline EPC Titer and Does Not Improve Angiographic Outcome in Coronary Artery Disease Patients Treated With the Genous™ Stent
Wijnand K. den Dekker et al.
CELL TRANSPLANTATION (2014)
Antiplatelet theRapy after Genous EPC-capturing coroNary stenT implantatiOn The ARGENTO Study: a prospective, multicenter registry
Salvatore Cassese et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Differences in cardiovascular risk factors and clinical outcomes between Western European and Southeast Asian patients treated with the Genous Bio-engineered R stent: an e-HEALING worldwide registry substudy
Margo Klomp et al.
CORONARY ARTERY DISEASE (2012)
Twelve-month clinical outcomes after coronary stenting with the Genous Bio-engineered R Stent in patients with a bifurcation lesion: from the e-HEALING (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth) registry
Marcel A. Beijk et al.
CORONARY ARTERY DISEASE (2012)
Time Course of Endothelium-Dependent and -Independent Coronary Vasomotor Response to Coronary Balloons and Stents Comparison of Plain and Drug-Eluting Balloons and Stents
Christian A. Plass et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2012)
Effectiveness and Safety of the Genous Endothelial Progenitor Cell-Capture Stent in Acute ST-Elevation Myocardial Infarction
Adrian F. Low et al.
AMERICAN JOURNAL OF CARDIOLOGY (2011)
Final results of the HEALING IIB trial to evaluate a bio-engineered CD34 antibody coated stent (Genous™Stent) designed to promote vascular healing by capture of circulating endothelial progenitor cells in CAD patients
Wijnand K. den Dekker et al.
ATHEROSCLEROSIS (2011)
Two-Year Follow-Up of the Genous™ Endothelial Progenitor Cell Capturing Stent Versus the Taxus Liberte Stent in Patients With De Novo Coronary Artery Lesions With a High-Risk of Restenosis: A Randomized, Single-Center, Pilot Study
Marcel A. M. Beijk et al.
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS (2011)
Coronary Stenting With the Genous™ Bio-Engineered R Stent™ in Elderly Patients-12-Month Outcomes From the e-HEALING Registry
Peter Damman et al.
CIRCULATION JOURNAL (2011)
1-Year Outcome of TRIAS HR (TRI-Stent Adjudication Study-High Risk of Restenosis) A Multicenter, Randomized Trial Comparing Genous Endothelial Progenitor Cell Capturing Stents With Drug-Eluting Stents
Margo Klomp et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2011)
Three-Year Clinical Follow-Up of an Unselected Patient Population Treated with the Genous Endothelial Progenitor Cell Capturing Stent
Margo Klomp et al.
JOURNAL OF INTERVENTIONAL CARDIOLOGY (2011)
Clinical results after coronary stenting with the Genous™ Bio-engineered R stent™: 12-month outcomes of the e-HEALING (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth) worldwide registry
Sigmund Silber et al.
EUROINTERVENTION (2011)
Evaluating the safety of very short-term (10 days) dual antiplatelet therapy after Genous™ bio-engineered R stent™ implantation: the multicentre pilot GENOUS trial
Giuseppe M. Sangiorgi et al.
EUROINTERVENTION (2011)
Genous™ endothelial progenitor cell capturing stent vs. the Taxus Liberte stent in patients with de novo coronary lesions with a high-risk of coronary restenosis: a randomized, single-centre, pilot study
Marcel A. M. Beijk et al.
EUROPEAN HEART JOURNAL (2010)
Endothelial progenitor cell capture stent implantation in patients with ST-segment elevation acute myocardial infarction: one year follow-up
Yian-Ping Lee et al.
EUROINTERVENTION (2010)
Treatment of Acute Myocardial Infarction in Patients with Stimulant ST-segment Elevation
Frans Van de Werf et al.
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY (2009)
Use of Drug-Eluting Stents in Acute Myocardial Infarction A Systematic Review and Meta-Analysis
Somjot S. Brar et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Use of endothelial progenitor cell capture stent (Genous Bio-Engineered R Stent) during primary percutaneous coronary intervention in acute myocardial infarction: Intermediate- to long-term clinical follow-up
Melissa Co et al.
AMERICAN HEART JOURNAL (2008)
Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation
Frans Van de Werf et al.
EUROPEAN HEART JOURNAL (2008)
Clinical end points in coronary stent trials - A case for standardized definitions
Donald E. Cutlip et al.
CIRCULATION (2007)
Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice:: data from a large two-institutional cohort study
Joost Daemen et al.
LANCET (2007)
Transfer of endothelial progenitor and bone marrow cells influences atherosclerotic plaque size and composition in apolipoprotein E knockout mice
J George et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Endothelial progenitor cell capture by stents coated with antibody against CD34 - The HEALING-FIM (healthy endothelial accelerated lining inhibits neointimal growth-first in man) registry
J Aoki et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease
GW Stone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery
JW Moses et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions
A Colombo et al.
CIRCULATION (2003)
A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization.
M Morice et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
HMG-CoA reductase inhibitor mobilizes bone marrow-derived endothelial progenitor cells
J Llevadot et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease
M Vasa et al.
CIRCULATION (2001)
Share Paper
